@incollection{, 48D915FB8BE66CCFD7FF82F486D47308 , author={{RenpengDing} and {ShangLiu} and {HuanyiChen} and {BinKang} and {RadojeDrmanac} and {YingGu} and {University of Chinese Academy of Sciences}}, journal={{Global Journal of Medical Research}}, journal={{GJMR}}2249-46180975-588810.34257/GJMR, address={Cambridge, United States}, publisher={Global Journals Organisation}2081119 } @incollection{b0, , title={{Inhibitory B7-family molecules in the tumour microenvironment}} , author={{ WZou } and { Chen }} , journal={{Nat Rev Immunol}} 8 6 , year={2008} } @incollection{b1, , title={{The Emerging World of TCR-T Cell Trials Against Cancer: A Systematic Review}} , author={{ JZhang } and { LWang }} , journal={{Technol Cancer Res Treat}} 18 1533033819831068 , year={2019} } @book{b2, , title={{Engineered T Cells for glioblastoma therapy. Glioma}} , author={{ ZhuJianhong } and { ZhongJunjie }} , year={2018} 1 125 } @incollection{b3, , title={{Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression}} , author={{ MNishimura } and { HUmehara } and { TNakayama } and { OYoneda } and { KHieshima } and { MKakizaki }} , journal={{J Immunol}} 168 12 , year={2002} } @incollection{b4, , title={{Functional classification of memory CD8(+) T cells by CX3CR1 expression}} , author={{ JPBottcher } and { MBeyer } and { FMeissner } and { ZAbdullah } and { JSander } and { BHochst }} , journal={{Nat Commun}} 6 8306 , year={2015} } @book{b5, , title={{CD8+HLA-DR+ T cells are increased in patients}} , author={{ LXing } and { CLiu } and { RFu } and { HWang } and { JWang } and { XLiu }} }